Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.
Saved in:
| Title: | Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. |
|---|---|
| Authors: | Ching THW; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Amoroso L; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Bohner C; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., D'Amico E; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Eilbott J; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Entezar T; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Fitzpatrick M; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Fram G; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Grazioplene R; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Hokanson J; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Kichuk SA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Martins B; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Patel P; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Schaer H; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Shnayder S; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Witherow C; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Pittenger C; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.; Department of Psychology, Yale University, New Haven, CT, United States.; Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, United States.; Child Study Center, Yale University School of Medicine, New Haven, CT, United States., Kelmendi B; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2024 Jan 09; Vol. 14, pp. 1278823. Date of Electronic Publication: 2024 Jan 09 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38264632 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ching+THW%22">Ching THW</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Amoroso+L%22">Amoroso L</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Bohner+C%22">Bohner C</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22D'Amico+E%22">D'Amico E</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Eilbott+J%22">Eilbott J</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Entezar+T%22">Entezar T</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Fitzpatrick+M%22">Fitzpatrick M</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Fram+G%22">Fram G</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Grazioplene+R%22">Grazioplene R</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Hokanson+J%22">Hokanson J</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Kichuk+SA%22">Kichuk SA</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Martins+B%22">Martins B</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Patel+P%22">Patel P</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Schaer+H%22">Schaer H</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Shnayder+S%22">Shnayder S</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Witherow+C%22">Witherow C</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Pittenger+C%22">Pittenger C</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.; Department of Psychology, Yale University, New Haven, CT, United States.; Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, United States.; Child Study Center, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Kelmendi+B%22">Kelmendi B</searchLink>; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101545006%22">Frontiers in psychiatry</searchLink> [Front Psychiatry] 2024 Jan 09; Vol. 14, pp. 1278823. <i>Date of Electronic Publication: </i>2024 Jan 09 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101545006 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-0640 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216640640%22">16640640 </searchLink><i>NLM ISO Abbreviation: </i>Front Psychiatry <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38264632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fpsyt.2023.1278823 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1278823 Titles: – TitleFull: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ching THW – PersonEntity: Name: NameFull: Amoroso L – PersonEntity: Name: NameFull: Bohner C – PersonEntity: Name: NameFull: D'Amico E – PersonEntity: Name: NameFull: Eilbott J – PersonEntity: Name: NameFull: Entezar T – PersonEntity: Name: NameFull: Fitzpatrick M – PersonEntity: Name: NameFull: Fram G – PersonEntity: Name: NameFull: Grazioplene R – PersonEntity: Name: NameFull: Hokanson J – PersonEntity: Name: NameFull: Kichuk SA – PersonEntity: Name: NameFull: Martins B – PersonEntity: Name: NameFull: Patel P – PersonEntity: Name: NameFull: Schaer H – PersonEntity: Name: NameFull: Shnayder S – PersonEntity: Name: NameFull: Witherow C – PersonEntity: Name: NameFull: Pittenger C – PersonEntity: Name: NameFull: Kelmendi B IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 01 Text: 2024 Jan 09 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 1664-0640 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in psychiatry Type: main |
| ResultId | 1 |
